Target intelligence / Profile preview

Enterotoxigenic Escherichia coli colonization factor antigen I fimbriae tip adhesin (CfaE) (CfaE)

Target
CfaE
Molecular classification
Adhesin (bacterial), Fimbrial tip protein, Chaperone-usher pathway fimbriae minor subunit, Other
01

Overview

Enterotoxigenic Escherichia coli colonization factor antigen I fimbriae tip adhesin (CfaE) is the minor adhesive subunit located at the tip of CFA/I fimbriae, which are filamentous structures on the surface of ETEC, a major cause of travelers’ diarrhea and childhood diarrheal disease. CfaE is responsible for initiating the binding of ETEC to the small intestinal mucosa by recognizing and binding to specific receptors on host epithelial cells[2][3][4]. CfaE is crucial for the assembly of fimbriae through its interaction with the chaperone CfaA and the usher protein CfaC, and also operates under various biomechanical forces in vivo, enabling robust attachment during peristalsis and fluid flow[1][2]. The adhesive properties and essentiality of CfaE for ETEC colonization make it a lead target for anti-adhesion therapies and vaccine development[1][2][3]. No small molecule drugs are currently approved to inhibit CfaE, but its well-conserved structure makes it a promising candidate for interventions aiming to prevent ETEC-mediated infection.

Other names
CFA/I fimbriae tip adhesinColonization factor antigen I tip adhesinCfaE protein
02

Mechanism of action

Drugs or antibodies aiming to block CfaE function would inhibit the adhesion of ETEC to intestinal epithelial cells, preventing colonization and subsequent disease (anti-adhesive)[1].

03

Biological functions

Bacterial adhesion to host intestinal epithelial cellsInitiation of intestinal colonizationFacilitation of diarrheal disease by ETECOther
04

Disease associations

Infection (specifically enterotoxigenic Escherichia coli infection, travelers’ diarrhea, diarrheal disease)
05

Safety considerations

No specific intrinsic safety concerns identified for targeting CfaE; however, challenges include bacterial antigenic variation and possible off-target immunological effects due to similarity with other fimbrial adhesins[3].
06

Interacting drugs

None currently approved; research ongoing for small molecules or biologics that block CfaE or its interaction with host receptors[1].
07

Biomarkers

Presence of anti-CfaE antibodies may correlate with immune response or efficacy in vaccine trials targeting ETEC[1].

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli colonization factor antigen I fimbriae tip adhesin (CfaE) (CfaE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli colonization factor antigen I fimbriae tip adhesin (CfaE) (CfaE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call